首页 | 本学科首页   官方微博 | 高级检索  
     

氙气后处理对大鼠脊髓缺血再灌注损伤起保护作用:基于下调mTOR通路和抑制内质网应激介导的神经元凋亡
引用本文:罗 兰,佟家祺,李 璐,金 沐. 氙气后处理对大鼠脊髓缺血再灌注损伤起保护作用:基于下调mTOR通路和抑制内质网应激介导的神经元凋亡[J]. 南方医科大学学报, 2022, 42(8): 1256-1262. DOI: 10.12122/j.issn.1673-4254.2022.08.20
作者姓名:罗 兰  佟家祺  李 璐  金 沐
作者单位:首都医科大学附属北京友谊医院麻醉科,北京 100050
基金项目:北京市自然科学基金(7192047);
摘    要:目的 基于哺乳动物雷帕霉素靶蛋白(m TOR)通路和内质网应激(ERS)-凋亡通路探讨氙气后处理治疗大鼠脊髓缺血再灌注损伤(SCIRI)的作用机制。方法 将50只雄性SD大鼠随机分为5组:假手术组(Sham组),脊髓缺血再灌注组(I/R组),氙气后处理组(Xe组),脊髓缺血再灌注+雷帕霉素组(I/R+Rapa组),氙气后处理+雷帕霉素组(Xe+Rapa组)(10只/组)。通过夹闭腹主动脉85 min,再灌注4 h建立大鼠SCIRI模型。手术前3 d,I/R+Rapa组和Xe+Rapa组的大鼠每天予以腹腔注射雷帕霉素(Rapa,4 mg/kg),其余3组大鼠注射等体积的溶剂。缺血再灌注后1 h时,Xe组和Xe+Rapa组的大鼠经呼吸机吸入50%氙气+50%氧气混合气1 h。其余3组的大鼠予以50%氮气+50%氧气混合气1 h。于再灌注4 h观察记录大鼠后肢运动功能后收集标本,进行HE染色、尼氏染色计数正常神经元数量,Western blot和RT-PCR方法分别检测脊髓组织中内质网应激通路[葡萄糖调节蛋白78(GRP78)、激活转录因子6(ATF6)、肌醇需要酶1α(IRE1α)、RNA...

关 键 词:脊髓缺血再灌注损伤  氙气后处理  m TOR  内质网应激  凋亡

Xenon post-conditioning protects against spinal cord ischemia-reperfusion injury in rats by downregulating mTOR pathway and inhibiting endoplasmic reticulum stress-induced neuronal apoptosis
LUO Lan,TONG Jiaqi,LI Lu,JIN Mu. Xenon post-conditioning protects against spinal cord ischemia-reperfusion injury in rats by downregulating mTOR pathway and inhibiting endoplasmic reticulum stress-induced neuronal apoptosis[J]. Journal of Southern Medical University, 2022, 42(8): 1256-1262. DOI: 10.12122/j.issn.1673-4254.2022.08.20
Authors:LUO Lan  TONG Jiaqi  LI Lu  JIN Mu
Affiliation:Department of Anesthesiology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
Abstract:Objective The purpose of this study was to determine whether xenon post-conditioning affects mTOR signaling as well as endoplasmic reticulum stress (ERS)-apoptosis pathway in rats with spinal cord ischemia/reperfusion injury. Methods Fifty male rats were randomized equally into sham-operated group (Sham group), I/R model group (I/R group), I/R model + xenon post-conditioning group (Xe group), I/R model+rapamycin (a mTOR signaling pathway inhibitor) treatment group (I/R+ Rapa group), and I/R model + xenon post- conditioning with rapamycin treatment group (Xe + Rapa group). In the latter 4 groups, SCIRI was induced by clamping the abdominal aorta for 85 min followed by reperfusion for 4 h. Rapamycin (or vehicle) was administered by daily intraperitoneal injection (4 mg/kg) for 3 days before SCIRI, and xenon post-conditioning by inhalation of 1∶1 mixture of xenon and oxygen for 1 h at 1 h after initiation of reperfusion; the rats without xenon post-conditioning were given inhalation of nitrogen and oxygen (1∶1). After the reperfusion, motor function and histopathologic changes in the rats were examined. Western blotting and real-time PCR were used to detect the protein and mRNA expressions of GRP78, ATF6, IRE1α, PERK, mTOR, p-mTOR, Bax, Bcl-2 and caspase-3 in the spinal cord. Results The rats showed significantly lowered hind limb motor function following SCIRI (P<0.01) with a decreased count of normal neurons, increased mRNA and protein expressions of GRP78, ATF6, IRE1α, PERK, and caspase-3, and elevated p-mTOR/mTOR ratio and Bax/Bcl-2 ratio (P<0.01). Xenon post-conditioning significantly decreased the mRNA and protein levels of GRP78, ATF6, IRE1α, PERK and caspase-3 (P<0.05 or 0.01) and reduced p-mTOR/mTOR and Bax/Bcl-2 ratios (P<0.01) in rats with SCIRI; the mRNA contents and protein levels of GRP78 and ATF6 were significantly decreased in I/R +Rapa group (P< 0.01). Compared with those in Xe group, the rats in I/R+Rapa group and Xe+Rapa had significantly lowered BBB and Tarlov scores of the hind legs (P<0.01), and caspase-3 protein level and Bax/Bcl-2 ratio were significantly lowered in Xe+Rapa group (P<0.05 or 0.01). Conclusion By inhibiting ERS and neuronal apoptosis, xenon post-conditioning may have protective effects against SCIRI in rats. The mTOR signaling pathway is partially involved in this process.
Keywords:spinal cord ischemia/reperfusion injury   xenon post-conditioning   mTOR   endoplasmic reticulum stress   apoptosis,
点击此处可从《南方医科大学学报》浏览原始摘要信息
点击此处可从《南方医科大学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号